---
title: "Edgewise Therapeutics Insider Sold Shares Worth $287,316, According to a Recent SEC Filing"
date: "2025-02-08 05:44:38"
summary: "Kevin Koch, Director, President and CEO, on February 05, 2025, sold 9,536 shares in Edgewise Therapeutics for $287,316. Following the Form 4 filing with the SEC, Koch has control over a total of 353,262 common shares of the company, with 14,478 shares held directly and 338,784 controlled indirectly. SEC Filing:www.sec.gov/Archives/edgar/data/1710072/000156218025001025/xslF345X05/primarydocument.xml..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Kevin Koch, Director, President and CEO, on February 05,Â 2025, sold 9,536 shares in Edgewise Therapeutics for $287,316. Following the Form 4 filing with the SEC, Koch has control over a total of 353,262 common shares of the company, with 14,478 shares held directly and 338,784 controlled indirectly.

SEC Filing:

[www.sec.gov/Archives/edgar/data/1710072/000156218025001025/xslF345X05/primarydocument.xml](https://www.sec.gov/Archives/edgar/data/1710072/000156218025001025/xslF345X05/primarydocument.xml)

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:A3313066:0/)
